Sources, Health News, ET HealthWorld

New Delhi: The only Indian company Zydus Cadila that claims to have developed a neutralizing monoclonal antibody (mAbs) cocktail for the treatment of Covid-19 has been authorized to conduct clinical trials by the Subject Expert Committee (SEC) of Central Drugs Standard Control Organization (CDSCO), sources say. “The SEC gives a …

Read More »